JP2008519589A5 - - Google Patents

Download PDF

Info

Publication number
JP2008519589A5
JP2008519589A5 JP2007540582A JP2007540582A JP2008519589A5 JP 2008519589 A5 JP2008519589 A5 JP 2008519589A5 JP 2007540582 A JP2007540582 A JP 2007540582A JP 2007540582 A JP2007540582 A JP 2007540582A JP 2008519589 A5 JP2008519589 A5 JP 2008519589A5
Authority
JP
Japan
Prior art keywords
peptide
amino acid
sequence
independently selected
peptide according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007540582A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008519589A (ja
Filing date
Publication date
Priority claimed from US11/041,207 external-priority patent/US7589063B2/en
Application filed filed Critical
Priority claimed from PCT/EP2005/012075 external-priority patent/WO2006050959A2/en
Publication of JP2008519589A publication Critical patent/JP2008519589A/ja
Publication of JP2008519589A5 publication Critical patent/JP2008519589A5/ja
Pending legal-status Critical Current

Links

JP2007540582A 2004-11-10 2005-11-10 造血を促進する分子 Pending JP2008519589A (ja)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
DE102004054422 2004-11-10
EP04029536 2004-12-14
US11/041,207 US7589063B2 (en) 2004-12-14 2005-01-25 Molecules which promote hematopoiesis
EP05002113 2005-02-02
EP05012637 2005-06-13
EP05013594 2005-06-23
EP05020035 2005-09-14
PCT/EP2005/012075 WO2006050959A2 (en) 2004-11-10 2005-11-10 Molecules which promote hematopoiesis

Publications (2)

Publication Number Publication Date
JP2008519589A JP2008519589A (ja) 2008-06-12
JP2008519589A5 true JP2008519589A5 (enrdf_load_stackoverflow) 2008-12-25

Family

ID=36336855

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007540582A Pending JP2008519589A (ja) 2004-11-10 2005-11-10 造血を促進する分子

Country Status (7)

Country Link
EP (1) EP1812461A2 (enrdf_load_stackoverflow)
JP (1) JP2008519589A (enrdf_load_stackoverflow)
KR (1) KR20070092706A (enrdf_load_stackoverflow)
AU (1) AU2005303887A1 (enrdf_load_stackoverflow)
CA (1) CA2586915A1 (enrdf_load_stackoverflow)
NO (1) NO20072856L (enrdf_load_stackoverflow)
WO (1) WO2006050959A2 (enrdf_load_stackoverflow)

Families Citing this family (100)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7589063B2 (en) 2004-12-14 2009-09-15 Aplagen Gmbh Molecules which promote hematopoiesis
US8324159B2 (en) * 2005-06-03 2012-12-04 Affymax, Inc. Erythropoietin receptor peptide formulations and uses
US7919461B2 (en) * 2005-06-03 2011-04-05 Affymax, Inc. Erythropoietin receptor peptide formulations and uses
EP1907417A2 (en) * 2005-06-23 2008-04-09 AplaGen GmbH Supravalent compounds
MX2008011389A (es) * 2006-03-09 2009-01-26 Aplagen Gmbh Moleculas modificadas las cuales promueven hematopoyesis.
EP2018835B1 (de) 2007-07-09 2014-03-05 Augustinus Bader Wirkstoff abgebendes Pflaster
AU2008304111B2 (en) 2007-09-27 2014-04-24 Amgen Inc. Pharmaceutical formulations
AU2008317383B2 (en) 2007-10-23 2013-11-14 Nektar Therapeutics Hydroxyapatite-targeting multiarm polymers and conjugates made therefrom
ES2962777T3 (es) 2007-11-15 2024-03-21 Amgen Inc Formulación acuosa de anticuerpos estabilizada por antioxidantes para la administración parenteral
AU2009206306B2 (en) 2008-01-25 2013-06-06 Amgen Inc. Ferroportin antibodies and methods of use
JP2009191056A (ja) * 2008-02-15 2009-08-27 Affymax Inc 合成ペプチドをベースとするepoレセプターアゴニストを用いた抗エリスロポエチン抗体に媒介された障害の治療
CA2720587A1 (en) 2008-04-09 2009-10-15 Francis Barany Coferons and methods of making and using them
EP2294087B1 (en) 2008-05-01 2014-05-14 Amgen, Inc. Anti-hepcidin antibodies and methods of use
CA3019967A1 (en) 2008-11-13 2010-05-20 The General Hospital Corporation Methods and compositions for regulating iron homeostasis by modulation of bmp-6
WO2011012306A2 (en) 2009-07-30 2011-02-03 Aplagen Gmbh Use of emps for antagonising epo-stimulatory effects on epo-responsive tumors while maintaining erythropoiesis
US9771345B2 (en) 2009-10-07 2017-09-26 Cornell University Coferons and methods of making and using them
CA2778105C (en) 2009-10-23 2019-04-02 Amgen Inc. Vial adapter and system
WO2011098095A1 (en) 2010-02-09 2011-08-18 Aplagen Gmbh Peptides binding the tpo receptor
CN103025369B (zh) 2010-06-07 2016-07-06 安姆根有限公司 药物递送装置
DK2590666T3 (en) 2010-07-06 2017-07-17 Augustinus Bader TOPICAL APPLICATION OF ERYTHROPOIETIN FOR USE IN THE TREATMENT OF DAMAGE OF THE CORNS
EP2691065B1 (en) 2011-03-31 2017-03-01 Amgen Inc. Vial adapter and system
JP6038884B2 (ja) 2011-04-20 2016-12-07 アムゲン・インコーポレーテッド 自動式注射装置
CA3175560A1 (en) 2011-10-14 2013-04-18 Amgen Inc. Injector and method of assembly
EP3081249B1 (en) 2012-11-21 2020-12-30 Amgen Inc. Drug delivery device
NZ631098A (en) 2013-03-15 2016-09-30 Intrinsic Lifesciences Llc Anti-hepcidin antibodies and uses thereof
WO2014143770A1 (en) 2013-03-15 2014-09-18 Amgen Inc. Body contour adaptable autoinjector device
CA2904725C (en) 2013-03-15 2022-04-12 Amgen Inc. Drug cassette, autoinjector, and autoinjector system
TWI639453B (zh) 2013-03-15 2018-11-01 美商安美基公司 用於注射器之匣盒
IL292270B2 (en) 2013-03-22 2024-04-01 Amgen Inc Injector and method of assembly
ES2744837T3 (es) 2013-10-24 2020-02-26 Amgen Inc Inyector y procedimiento de ensamblaje
US10758683B2 (en) 2013-10-24 2020-09-01 Amgen Inc. Drug delivery system with temperature-sensitive control
WO2015119906A1 (en) 2014-02-05 2015-08-13 Amgen Inc. Drug delivery system with electromagnetic field generator
AU2015256082C1 (en) 2014-05-07 2020-09-10 Amgen Inc. Autoinjector with shock reducing elements
CA2948525A1 (en) 2014-06-03 2015-12-10 Amgen Inc. Controllable drug delivery system and method of use
NZ730186A (en) 2014-09-22 2020-04-24 Intrinsic Lifesciences Llc Humanized anti-hepcidin antibodies and uses thereof
CA2957960C (en) 2014-10-14 2023-08-22 Amgen, Inc. Drug injection device with visual and audible indicators
US10799630B2 (en) 2014-12-19 2020-10-13 Amgen Inc. Drug delivery device with proximity sensor
US11357916B2 (en) 2014-12-19 2022-06-14 Amgen Inc. Drug delivery device with live button or user interface field
WO2016133947A1 (en) 2015-02-17 2016-08-25 Amgen Inc. Drug delivery device with vacuum assisted securement and/or feedback
US11806509B2 (en) 2015-02-27 2023-11-07 Amgen Inc. Drug delivery device having a needle guard mechanism with a turnable threshold of resistance to needle guard movement
WO2017039786A1 (en) 2015-09-02 2017-03-09 Amgen Inc. Syringe assembly adapter for a syringe
JP7082568B2 (ja) 2015-12-09 2022-06-08 アムジエン・インコーポレーテツド 信号伝達キャップ付き自動注射器
WO2017120178A1 (en) 2016-01-06 2017-07-13 Amgen Inc. Auto-injector with signaling electronics
DK3429663T3 (da) 2016-03-15 2020-09-28 Amgen Inc Reduktion af sandsynligheden for glasbrud i anordninger til indgivelse af lægemidler
US11541168B2 (en) 2016-04-29 2023-01-03 Amgen Inc. Drug delivery device with messaging label
US11389588B2 (en) 2016-05-02 2022-07-19 Amgen Inc. Syringe adapter and guide for filling an on-body injector
EP3455142B1 (en) 2016-05-13 2023-08-09 Amgen Inc. Vial sleeve assembly
EP3458988B1 (en) 2016-05-16 2023-10-18 Amgen Inc. Data encryption in medical devices with limited computational capability
US11541176B2 (en) 2016-06-03 2023-01-03 Amgen Inc. Impact testing apparatuses and methods for drug delivery devices
WO2018004842A1 (en) 2016-07-01 2018-01-04 Amgen Inc. Drug delivery device having minimized risk of component fracture upon impact events
US20190328965A1 (en) 2016-08-17 2019-10-31 Amgen Inc. Drug delivery device with placement detection
EP3532127A1 (en) 2016-10-25 2019-09-04 Amgen Inc. On-body injector
MX2019008432A (es) 2017-01-17 2019-11-18 Amgen Inc Dispositivos de inyeccion y metodos relacionados de uso y ensamblaje.
JP7064501B2 (ja) 2017-02-17 2022-05-10 アムジエン・インコーポレーテツド 無菌流体流路を備える薬物送達デバイスおよび関連する組立方法
MX2019009755A (es) 2017-02-17 2019-10-07 Amgen Inc Mecanismo de insercion para dispositivo de suministro de farmacos.
MX2019010544A (es) 2017-03-06 2019-10-21 Amgen Inc Dispositivo de administracion de farmacos con caracteristica de prevencion de la activacion.
JP2020509839A (ja) 2017-03-07 2020-04-02 アムジエン・インコーポレーテツド 超過圧力による針の挿入
WO2018165499A1 (en) 2017-03-09 2018-09-13 Amgen Inc. Insertion mechanism for drug delivery device
EP3570871B1 (en) 2017-03-20 2020-11-18 H. Hoffnabb-La Roche Ag Method for in vitro glycoengineering of an erythropoiesis stimulating protein
FI3600491T3 (fi) 2017-03-28 2023-10-20 Amgen Inc Männänvarren ja ruiskukokoonpanon järjestelmä ja menetelmä
AU2018280054B2 (en) 2017-06-08 2023-07-13 Amgen Inc. Syringe assembly for a drug delivery device and method of assembly
US11904143B2 (en) 2017-06-08 2024-02-20 Amgen Inc. Torque driven drug delivery device
EP3641857A1 (en) 2017-06-22 2020-04-29 Amgen Inc. Device activation impact/shock reduction
WO2018237225A1 (en) 2017-06-23 2018-12-27 Amgen Inc. Electronic drug delivery device comprising a cap activated by a switch assembly
EP3651832B1 (en) 2017-07-14 2023-12-13 Amgen Inc. Needle insertion-retraction system having dual torsion spring system
WO2019018169A1 (en) 2017-07-21 2019-01-24 Amgen Inc. PERMEABLE GAS SEALING ELEMENT FOR MEDICINE CONTAINER AND METHODS OF ASSEMBLY
JP2020528296A (ja) 2017-07-25 2020-09-24 アムジエン・インコーポレーテツド ギヤモジュールを有する薬物送達デバイス及び関連する組立方法
US11484648B2 (en) 2017-07-25 2022-11-01 Amgen Inc. Drug delivery device with container access system and related method of assembly
MA49838A (fr) 2017-08-09 2020-06-17 Amgen Inc Systèm de administration de médicaments avec pression hydraulique-pneumatique de chambre
EP3668567A1 (en) 2017-08-18 2020-06-24 Amgen Inc. Wearable injector with sterile adhesive patch
US11103636B2 (en) 2017-08-22 2021-08-31 Amgen Inc. Needle insertion mechanism for drug delivery device
US11759565B2 (en) 2017-10-04 2023-09-19 Amgen Inc. Flow adapter for drug delivery device
EP4257164A3 (en) 2017-10-06 2024-01-17 Amgen Inc. Drug delivery device with interlock assembly and related method of assembly
EP3694578A1 (en) 2017-10-09 2020-08-19 Amgen Inc. Drug delivery device with drive assembly and related method of assembly
IL273582B2 (en) 2017-11-03 2024-12-01 Amgen Inc Systems and approaches for sterilizing a drug delivery device
EP3707075A1 (en) 2017-11-06 2020-09-16 Amgen Inc. Fill-finish assemblies and related methods
ES2994389T3 (en) 2017-11-06 2025-01-23 Amgen Inc Drug delivery device with placement and flow sensing
JP7247174B2 (ja) 2017-11-10 2023-03-28 アムジエン・インコーポレーテツド 薬物送達デバイスのプランジャ
SG11202003004RA (en) 2017-11-16 2020-04-29 Amgen Inc Door latch mechanism for drug delivery device
EP3710089A1 (en) 2017-11-16 2020-09-23 Amgen Inc. Autoinjector with stall and end point detection
US10835685B2 (en) 2018-05-30 2020-11-17 Amgen Inc. Thermal spring release mechanism for a drug delivery device
US11083840B2 (en) 2018-06-01 2021-08-10 Amgen Inc. Modular fluid path assemblies for drug delivery devices
US12303677B2 (en) 2018-07-24 2025-05-20 Amgen Inc. Hybrid drug delivery devices with optional grip portion and related method of preparation
US12042645B2 (en) 2018-07-24 2024-07-23 Amgen Inc. Delivery devices for administering drugs
WO2020023336A1 (en) 2018-07-24 2020-01-30 Amgen Inc. Hybrid drug delivery devices with grip portion
CA3103682A1 (en) 2018-07-24 2020-01-30 Amgen Inc. Delivery devices for administering drugs
CA3103105A1 (en) 2018-07-31 2020-02-06 Amgen Inc. Fluid path assembly for a drug delivery device
EP3856284A1 (en) 2018-09-24 2021-08-04 Amgen Inc. Interventional dosing systems and methods
CA3110371A1 (en) 2018-09-28 2020-04-02 Amgen Inc. Muscle wire escapement activation assembly for a drug delivery device
MA53815A (fr) 2018-10-02 2022-01-05 Amgen Inc Systèmes d'injection pour administration de médicament avec transmission de force interne
TWI824026B (zh) 2018-10-05 2023-12-01 美商安進公司 具有劑量指示器之藥物遞送裝置
MX2021004219A (es) 2018-10-15 2021-05-27 Amgen Inc Dispositivo de administracion de farmacos con mecanismo de amortiguacion.
CA3109988A1 (en) 2018-10-15 2020-04-23 Amgen Inc. Platform assembly process for drug delivery device
TWI831847B (zh) 2018-11-01 2024-02-11 美商安進公司 部分針頭縮回之藥物遞送裝置及其操作方法
MA54057A (fr) 2018-11-01 2022-02-09 Amgen Inc Dispositifs d'administration de médicament à rétraction partielle d'élément d'administration de médicament
ES3010833T3 (en) 2018-11-01 2025-04-04 Amgen Inc Drug delivery devices with partial drug delivery member retraction
MX2021012557A (es) 2019-04-24 2021-11-12 Amgen Inc Conjuntos y metodos de verificacion de esterilizacion de jeringuillas.
MX2022002149A (es) 2019-08-23 2022-03-17 Amgen Inc Dispositivo de suministro de farmacos con componentes de acoplamiento de capuchon de aguja configurable y metodos relacionados.
WO2022246055A1 (en) 2021-05-21 2022-11-24 Amgen Inc. Method of optimizing a filling recipe for a drug container
IL319976A (en) 2022-11-02 2025-05-01 Hoffmann La Roche Method for producing glycoprotein compositions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3924746A1 (de) * 1989-07-26 1991-01-31 Behringwerke Ag Erythropoietin (epo)-peptide und dagegen gerichtete antikoerper
NZ310804A (en) * 1995-06-07 1998-10-28 Ortho Pharma Corp Compounds and peptides that bind to the erythropoietin receptor
MXPA05000202A (es) * 2002-06-28 2005-09-30 Johnson & Johnson Cuerpos mimeicos ch1-deletados de epo de mimetica de mamifero.

Similar Documents

Publication Publication Date Title
JP2008519589A5 (enrdf_load_stackoverflow)
JP2007530441A5 (enrdf_load_stackoverflow)
JP2009529509A5 (enrdf_load_stackoverflow)
JP2022133360A (ja) Apj受容体アゴニストおよびその使用
JP2023153945A (ja) 細胞透過性ペプチド、それを含んだコンジュゲート、及びそれを含んだ組成物
JP4949844B2 (ja) エリスロポエチン受容体に結合する新規ペプチド
JP4768795B2 (ja) エリスロポエチン受容体に結合する新規ペプチド
JP2010534486A5 (enrdf_load_stackoverflow)
EP1812461A2 (en) Molecules which promote hematopoiesis
JP2006527773A5 (enrdf_load_stackoverflow)
KR101972012B1 (ko) 세포 투과성 스테이플 펩타이드, 이의 제조방법 및 그 용도
JP2013518115A5 (enrdf_load_stackoverflow)
DK0481000T3 (da) Receptorer for fibroblastvækstfaktorer
CN103415530A (zh) 新型的含有非肽性交联结构的交联肽、以及该交联肽的合成方法和用于该方法的新型有机化合物
WO2007000672A3 (en) Peptidic antagonists of class iii semaphorins/neuropilins complexes
WO2006062685A2 (en) Novel peptides that bind to the erythropoietin receptor
CA2088804A1 (en) Tgf-beta induced gene and protein
CN1871022B (zh) 结合血小板生成素受体的肽和化合物
WO2013173755A1 (en) Modification of peptides using a bis(thioether)arylbridge approach
RU2007118385A (ru) Контрастные агенты для направлений доставки во внеклеточный матрикс
WO2008028645A1 (en) Peptides binding the tpo receptor
Lu et al. Number and placement of hydrophobic residues in a longitudinal strip governs helix formation of peptides in the presence of lipid vesicles
KR20070108140A (ko) 에리트로포이에틴 수용체에 결합하는 신규한 펩타이드
DK1973944T3 (en) Fgf2-binding peptides and uses thereof
JP5034005B2 (ja) 細胞死誘導ペプチド、map化細胞死誘導ペプチド、細胞死誘導剤及び抗癌剤